• 24. Faust R, Garratt PJ, Jones R, Yeh LK, Tsotinis A, Panoussopoulou M, Calogeropoulou T, Teh MT, Sugden D. (2000)
    Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
    J Med Chem, 43 (6): 1050-61. [PMID:10737738]
  • 25. Flaugh ME, Crowell TA, Clemens JA, Sawyer BD. (1979)
    Synthesis and evaluation of the antiovulatory activity of a variety of melatonin analogues.
    J Med Chem, 22 (1): 63-9. [PMID:423184]
  • 26. Garratt PJ, Jones R, Tocher DA, Sugden D. (1995)
    Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines.
    J Med Chem, 38 (7): 1132-9. [PMID:7707316]
  • 27. Garratt PJ, Travard S, Vonhoff S, Tsotinis A, Sugden D. (1996)
    Mapping the melatonin receptor. 4. Comparison of the binding affinities of a series of substituted phenylalkyl amides.
    J Med Chem, 39 (9): 1797-805. [PMID:8627603]
  • 28. Garrett PJ, Jones R, Rowe SJ, Sugden D. (1994)
    Mapping the melatonin receptor. 1. The 5-methoxyl group of melatonin is not an essential requirement for biological activity.
    Bioorg Med Chem Lett, 4: 1555-1558.
  • 29. Garrett PJ, Vonhoff S, Rowe S, Sugden D. (1994)
    Mapping of the melatonin receptor. 2. Synthesis and biological activity of indole derived melatonin analogues with restricted conformations of the C-3 amido ethane side chain.
    Bioorg Med Chem Lett, 4: 1559-1564.